Rational design of an immunoconjugate for selective knock-down of leukemia-specific E2A-PBX1 fusion gene expression in human Pre-B leukemia.
about
CD19-antigen specific nanoscale liposomal formulation of a SYK P-site inhibitor causes apoptotic destruction of human B-precursor leukemia cells.Novel Targeted Therapy for Precursor B Cell Acute Lymphoblastic Leukemia: anti-CD22 Antibody-MXD3 Antisense Oligonucleotide Conjugate.Oligonucleotide conjugates for therapeutic applications.Antibody-Antisense Oligonucleotide Conjugate Downregulates a Key Gene in Glioblastoma Stem Cells.
P2860
Rational design of an immunoconjugate for selective knock-down of leukemia-specific E2A-PBX1 fusion gene expression in human Pre-B leukemia.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Rational design of an immunoco ...... ssion in human Pre-B leukemia.
@en
type
label
Rational design of an immunoco ...... ssion in human Pre-B leukemia.
@en
prefLabel
Rational design of an immunoco ...... ssion in human Pre-B leukemia.
@en
P2093
P2860
P356
P1433
P1476
Rational design of an immunoco ...... ssion in human Pre-B leukemia.
@en
P2093
Dorothea E Myers
Ilker Dibirdik
Sanjive Qazi
P2860
P304
P356
10.1039/C2IB20114C
P577
2013-01-01T00:00:00Z